Crossref
Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway
MEDS Public Health and Preventive Medicine · 2026 · 6
DOI: 10.23977/phpm.2026.060108 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Public Health and Preventive Medicine, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway. MEDS Public Health and Preventive Medicine, 6. https://doi.org/10.23977/phpm.2026.060108
Vancouver
Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway. MEDS Public Health and Preventive Medicine. 2026;6. doi:10.23977/phpm.2026.060108
BibTeX
@article{euvimed2026,
title = {Pterostilbene Inhibits Hepatocellular Carcinoma by Regulating the MAPK Signaling Pathway},
journal = {MEDS Public Health and Preventive Medicine},
year = {2026},
volume = {6},
doi = {10.23977/phpm.2026.060108}
}
EUVIMED